Frank W.G. Leebeek, MD, PhD

Head of Department – Hematology · Erasmus MC · company speakers →

Frank W.G. Leebeek coordinates a research team on haemostasis and thrombosis with several research areas, mainly inherited bleeding disorders, including von Willebrand disease and hemophilia. He is steering committee member of several studies on new treatments for patients with bleedings disorders, including gene therapy. He is the principal investigator of the Willebrand in the Netherlands (WiN) and WiN-PRO study.

healthcare-servicespharma-biotech

Is this you? Claim this profile →

No public contact links on file.

Speaking history

World Federation of Hemophilia World Congress

19 April 2026 Kuala Lumpur, Malaysia “Diagnosis and treatment of von Willebrand Disease in 2024 and beyond”

Topics this speaker covers

healthcare-servicespharma-biotech

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →